C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
7.31
↓ 69% below average
Average (6y)
23.59
Historical baseline
Range
High:47.65
Low:7.31
CAGR
-14.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 7.31 | -32.6% |
| 2023 | 10.83 | -2.5% |
| 2022 | 11.12 | -64.9% |
| 2021 | 31.65 | -17.1% |
| 2020 | 38.19 | -19.9% |
| 2019 | 47.65 | +159.8% |
| 2018 | 18.34 | - |